These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7645179)

  • 1. [Morphological features of vitreoretinal proliferation, complicating dystrophic retinal detachment and experimental models].
    Balashova LM; Evgrafov VIu
    Vestn Oftalmol; 1995; 111(2):37-9. PubMed ID: 7645179
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytological study of subretinal fluid].
    Xu X; He Z
    Zhonghua Yan Ke Za Zhi; 1997 Nov; 33(6):450-2. PubMed ID: 10680550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-immunological studies in dystrophic retinal detachment complicated by proliferative vitreoretinopathy].
    Balashova LM; Saksonova EO; Zaĭtseva NS; Slepova OS; Teplinskaia LE; Il'nitskiĭ VV; Grishin VL
    Vestn Oftalmol; 1996; 112(2):38-41. PubMed ID: 9045489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
    Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental simulation of proliferatice vutreoretinopathy].
    Krivosheina OI; Zapuskalov IV
    Vestn Oftalmol; 2007; 123(1):44-8. PubMed ID: 17361806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stages of cell proliferation in an experimental model of vitreoretinal proliferation following injection of platelet-rich plasma].
    Pisella PJ; Baudouin C
    J Fr Ophtalmol; 1996; 19(10):576-84. PubMed ID: 8959097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
    Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
    Sethi CS; Lewis GP; Fisher SK; Leitner WP; Mann DL; Luthert PJ; Charteris DG
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RPE-associated extracellular matrix changes accompany retinal vascular proliferation and retino-vitreal membranes in a new model for proliferative retinopathy: the dystrophic rat.
    Caldwell RB; Slapnick SM; Roque RS
    Prog Clin Biol Res; 1989; 314():393-407. PubMed ID: 2608671
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemistry of cellular proliferation in eyes with longstanding retinal detachment.
    Mietz H; Stödtler M; Wiedemann P; Heimann K
    Int Ophthalmol; 1994-1995; 18(6):329-37. PubMed ID: 7642333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.
    Kumar A; Tewari HK; Bathwal DP; Khosla PK
    Indian J Ophthalmol; 1994 Mar; 42(1):31-5. PubMed ID: 7927629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases.
    Stödtler M; Mietz H; Wiedemann P; Heimann K
    Int Ophthalmol; 1994-1995; 18(6):323-8. PubMed ID: 7642332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiology of proliferative vitreoretinopathy.
    Wiedemann P; Weller M
    Acta Ophthalmol Suppl (1985); 1988; 189():3-15. PubMed ID: 2851252
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment.
    Eibl KH; Lewis GP; Betts K; Linberg KA; Gandorfer A; Kampik A; Fisher SK
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1305-11. PubMed ID: 17325177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy.
    Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X
    Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
    Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
    Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal adhesion.
    Kain HL
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():486-93. PubMed ID: 6589867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive preretinal proliferation. I. Histology].
    Laqua H; Machemer R
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1977; 74():357-63. PubMed ID: 406892
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study.
    Khoroshilova-Maslova IP; Leparskaya NL; Nabieva MM; Andreeva LD
    Bull Exp Biol Med; 2015 May; 159(1):100-2. PubMed ID: 26033599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinal-pigment epithelial interface.
    Foulds WS
    Br J Ophthalmol; 1979 Feb; 63(2):71-84. PubMed ID: 427074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.